 Ronald Freund
Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Term Potentiation | 10 | 2023 | 145 | 1.510 |
Why?
| | Hippocampus | 20 | 2023 | 709 | 1.460 |
Why?
| | Ethanol | 14 | 2012 | 548 | 1.180 |
Why?
| | Cerebellum | 8 | 2012 | 200 | 1.050 |
Why?
| | Mice, Inbred C3H | 5 | 2016 | 244 | 0.630 |
Why?
| | Amyloid beta-Peptides | 2 | 2021 | 191 | 0.620 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2023 | 158 | 0.560 |
Why?
| | Purkinje Cells | 10 | 2003 | 66 | 0.550 |
Why?
| | Dendritic Spines | 2 | 2016 | 49 | 0.540 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2016 | 96 | 0.520 |
Why?
| | Amyloid | 1 | 2016 | 82 | 0.500 |
Why?
| | Neurons | 9 | 2016 | 1298 | 0.490 |
Why?
| | Nicotine | 7 | 1997 | 266 | 0.480 |
Why?
| | Long-Term Synaptic Depression | 3 | 2021 | 48 | 0.430 |
Why?
| | Enzyme Inhibitors | 1 | 2016 | 757 | 0.420 |
Why?
| | Peptide Fragments | 2 | 2016 | 675 | 0.410 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 4773 | 0.400 |
Why?
| | Central Nervous System Depressants | 4 | 2011 | 82 | 0.400 |
Why?
| | gamma-Aminobutyric Acid | 7 | 2006 | 151 | 0.400 |
Why?
| | In Vitro Techniques | 13 | 2016 | 1044 | 0.340 |
Why?
| | Receptors, GABA-A | 4 | 2022 | 88 | 0.340 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2021 | 131 | 0.320 |
Why?
| | Receptors, Adrenergic, beta | 4 | 1997 | 133 | 0.310 |
Why?
| | Receptors, AMPA | 3 | 2021 | 120 | 0.300 |
Why?
| | Calcineurin | 2 | 2021 | 84 | 0.290 |
Why?
| | A Kinase Anchor Proteins | 2 | 2021 | 65 | 0.290 |
Why?
| | Synapses | 5 | 2023 | 336 | 0.270 |
Why?
| | Animals | 39 | 2023 | 32102 | 0.260 |
Why?
| | Calcium | 3 | 2023 | 1103 | 0.250 |
Why?
| | Norepinephrine | 2 | 2003 | 207 | 0.240 |
Why?
| | Rats | 21 | 2014 | 5034 | 0.210 |
Why?
| | Species Specificity | 5 | 2016 | 552 | 0.210 |
Why?
| | Neuronal Plasticity | 3 | 2023 | 214 | 0.210 |
Why?
| | Synaptic Transmission | 4 | 2006 | 232 | 0.210 |
Why?
| | Action Potentials | 7 | 2012 | 410 | 0.200 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2014 | 182 | 0.200 |
Why?
| | Calcium Channels, L-Type | 1 | 2022 | 107 | 0.190 |
Why?
| | Receptors, Nicotinic | 2 | 1997 | 273 | 0.190 |
Why?
| | Rats, Sprague-Dawley | 13 | 2014 | 2262 | 0.190 |
Why?
| | Second Messenger Systems | 2 | 1997 | 32 | 0.180 |
Why?
| | Mice | 18 | 2023 | 15052 | 0.180 |
Why?
| | Phosphorylation | 7 | 2023 | 1571 | 0.170 |
Why?
| | Mice, Inbred DBA | 6 | 1990 | 173 | 0.170 |
Why?
| | Mecamylamine | 3 | 1997 | 8 | 0.140 |
Why?
| | Receptors, GABA | 1 | 1997 | 9 | 0.140 |
Why?
| | Glutamic Acid | 4 | 2023 | 213 | 0.140 |
Why?
| | Bicuculline | 4 | 2008 | 21 | 0.140 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1996 | 17 | 0.140 |
Why?
| | Cyclic AMP | 1 | 1997 | 227 | 0.130 |
Why?
| | Thiones | 1 | 2016 | 14 | 0.130 |
Why?
| | Sensory Gating | 1 | 2016 | 38 | 0.130 |
Why?
| | Kinetics | 3 | 2016 | 1569 | 0.120 |
Why?
| | Acoustic Stimulation | 1 | 2016 | 313 | 0.120 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2014 | 36 | 0.120 |
Why?
| | Electric Stimulation | 7 | 2012 | 263 | 0.120 |
Why?
| | Leukotrienes | 1 | 2014 | 35 | 0.120 |
Why?
| | Learning | 2 | 2023 | 358 | 0.110 |
Why?
| | Excitatory Postsynaptic Potentials | 4 | 2021 | 101 | 0.110 |
Why?
| | Pyrimidines | 1 | 2016 | 376 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2016 | 2604 | 0.100 |
Why?
| | CA1 Region, Hippocampal | 2 | 2022 | 29 | 0.100 |
Why?
| | Indoles | 1 | 2014 | 309 | 0.100 |
Why?
| | Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2011 | 8 | 0.100 |
Why?
| | Synaptic Potentials | 1 | 2011 | 17 | 0.100 |
Why?
| | Electroencephalography | 1 | 1993 | 365 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2016 | 3914 | 0.090 |
Why?
| | Male | 21 | 2022 | 55949 | 0.090 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 399 | 0.090 |
Why?
| | Cognition Disorders | 1 | 2014 | 475 | 0.090 |
Why?
| | Phosphoserine | 4 | 2014 | 33 | 0.080 |
Why?
| | Brain Injuries | 1 | 2014 | 451 | 0.080 |
Why?
| | Seizures | 3 | 1990 | 344 | 0.080 |
Why?
| | Memory | 1 | 2010 | 211 | 0.080 |
Why?
| | Fear | 1 | 2011 | 297 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2010 | 1870 | 0.080 |
Why?
| | Corticosterone | 1 | 1988 | 248 | 0.070 |
Why?
| | Glutamates | 2 | 1984 | 59 | 0.070 |
Why?
| | Female | 13 | 2016 | 59913 | 0.070 |
Why?
| | Fetal Tissue Transplantation | 2 | 1997 | 35 | 0.070 |
Why?
| | Patch-Clamp Techniques | 3 | 2012 | 245 | 0.060 |
Why?
| | Isoproterenol | 3 | 1994 | 110 | 0.060 |
Why?
| | Evoked Potentials | 3 | 1993 | 110 | 0.060 |
Why?
| | Nomifensine | 1 | 2003 | 3 | 0.060 |
Why?
| | Spinal Cord | 2 | 1997 | 351 | 0.060 |
Why?
| | Microelectrodes | 1 | 2003 | 32 | 0.050 |
Why?
| | Electrochemistry | 1 | 2003 | 79 | 0.050 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2003 | 54 | 0.050 |
Why?
| | Syndactyly | 1 | 2022 | 10 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2021 | 1970 | 0.050 |
Why?
| | Optogenetics | 1 | 2023 | 95 | 0.050 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2021 | 16 | 0.050 |
Why?
| | Receptors, Glutamate | 1 | 2021 | 19 | 0.050 |
Why?
| | Spermine | 1 | 2021 | 27 | 0.050 |
Why?
| | Long QT Syndrome | 1 | 2022 | 59 | 0.050 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2001 | 68 | 0.050 |
Why?
| | Brain Tissue Transplantation | 1 | 2001 | 19 | 0.050 |
Why?
| | Nerve Degeneration | 1 | 2001 | 40 | 0.050 |
Why?
| | Subcellular Fractions | 2 | 2012 | 78 | 0.050 |
Why?
| | Substantia Nigra | 1 | 2001 | 37 | 0.050 |
Why?
| | Neural Inhibition | 2 | 2010 | 152 | 0.050 |
Why?
| | Immunoprecipitation | 2 | 2012 | 154 | 0.050 |
Why?
| | Quinoxalines | 2 | 2012 | 61 | 0.040 |
Why?
| | Autistic Disorder | 1 | 2022 | 163 | 0.040 |
Why?
| | Protein Binding | 2 | 2023 | 1917 | 0.040 |
Why?
| | N-Methylaspartate | 2 | 2012 | 37 | 0.040 |
Why?
| | Corpus Striatum | 1 | 2001 | 124 | 0.040 |
Why?
| | Iontophoresis | 2 | 1997 | 13 | 0.040 |
Why?
| | Benzylamines | 2 | 2010 | 39 | 0.040 |
Why?
| | Mutation | 2 | 2022 | 3364 | 0.040 |
Why?
| | GABA Antagonists | 2 | 2008 | 32 | 0.040 |
Why?
| | Electrophysiology | 4 | 1997 | 202 | 0.040 |
Why?
| | Stilbamidines | 1 | 1997 | 10 | 0.040 |
Why?
| | Graft Survival | 2 | 1997 | 480 | 0.040 |
Why?
| | GABA Modulators | 1 | 1997 | 9 | 0.040 |
Why?
| | Ganglia, Spinal | 1 | 1997 | 42 | 0.040 |
Why?
| | Receptor, IGF Type 1 | 1 | 1997 | 58 | 0.040 |
Why?
| | Aminobutyrates | 3 | 1985 | 32 | 0.030 |
Why?
| | Phosphoproteins | 1 | 1997 | 304 | 0.030 |
Why?
| | Transplantation, Heterotopic | 1 | 1994 | 16 | 0.030 |
Why?
| | Maze Learning | 1 | 2014 | 87 | 0.030 |
Why?
| | Serine | 2 | 2012 | 125 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2014 | 2000 | 0.030 |
Why?
| | Epilepsy | 2 | 1987 | 290 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2014 | 357 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2010 | 472 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2014 | 2790 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2022 | 3580 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2012 | 13 | 0.030 |
Why?
| | Silver Staining | 1 | 2012 | 17 | 0.030 |
Why?
| | Interneurons | 1 | 1993 | 99 | 0.030 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2012 | 16 | 0.030 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2012 | 37 | 0.030 |
Why?
| | Sodium Channel Blockers | 1 | 2012 | 23 | 0.030 |
Why?
| | Tetrodotoxin | 1 | 2012 | 40 | 0.030 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2012 | 89 | 0.030 |
Why?
| | Biophysics | 1 | 2012 | 70 | 0.030 |
Why?
| | Brain | 2 | 2014 | 2370 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2014 | 414 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 920 | 0.020 |
Why?
| | Amnesia | 1 | 2011 | 42 | 0.020 |
Why?
| | Pyramidal Tracts | 1 | 1990 | 20 | 0.020 |
Why?
| | Pregnanolone | 1 | 1990 | 21 | 0.020 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 20 | 0.020 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 12 | 0.020 |
Why?
| | Atropine | 1 | 1990 | 31 | 0.020 |
Why?
| | Nicotinic Antagonists | 1 | 1990 | 20 | 0.020 |
Why?
| | Bungarotoxins | 1 | 1990 | 44 | 0.020 |
Why?
| | Depression, Chemical | 2 | 1993 | 23 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2010 | 87 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1227 | 0.020 |
Why?
| | Phenanthrolines | 1 | 2008 | 8 | 0.020 |
Why?
| | Flurazepam | 1 | 1988 | 1 | 0.020 |
Why?
| | Biophysical Phenomena | 1 | 2008 | 63 | 0.020 |
Why?
| | Mice, Inbred A | 1 | 1988 | 45 | 0.020 |
Why?
| | Flunitrazepam | 1 | 1988 | 2 | 0.020 |
Why?
| | Allylglycine | 1 | 1988 | 2 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4541 | 0.020 |
Why?
| | Anticonvulsants | 1 | 1990 | 181 | 0.020 |
Why?
| | Ataxia | 2 | 1999 | 35 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1988 | 116 | 0.020 |
Why?
| | Tyrosine | 1 | 2008 | 219 | 0.020 |
Why?
| | Body Temperature | 1 | 1988 | 211 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 1988 | 162 | 0.020 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2008 | 147 | 0.020 |
Why?
| | Drug Tolerance | 2 | 1999 | 79 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2008 | 102 | 0.020 |
Why?
| | Protein Subunits | 1 | 2008 | 204 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 616 | 0.020 |
Why?
| | Rats, Inbred Strains | 2 | 1985 | 376 | 0.020 |
Why?
| | Protein Transport | 1 | 2008 | 400 | 0.020 |
Why?
| | Reference Values | 1 | 1988 | 744 | 0.020 |
Why?
| | Sulfonamides | 1 | 2010 | 447 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2012 | 1024 | 0.020 |
Why?
| | Phosphinic Acids | 1 | 2006 | 9 | 0.020 |
Why?
| | Receptors, GABA-B | 1 | 2006 | 7 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2010 | 701 | 0.020 |
Why?
| | Psychomotor Performance | 1 | 1988 | 278 | 0.020 |
Why?
| | Ophthalmologic Surgical Procedures | 2 | 1997 | 58 | 0.020 |
Why?
| | Neural Pathways | 2 | 1984 | 260 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 1994 | 1447 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 1987 | 316 | 0.020 |
Why?
| | Time Factors | 2 | 1997 | 6165 | 0.020 |
Why?
| | Sleep | 2 | 2006 | 625 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 790 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1984 | 511 | 0.010 |
Why?
| | Drug Synergism | 2 | 1994 | 317 | 0.010 |
Why?
| | Immunohistochemistry | 2 | 1997 | 1642 | 0.010 |
Why?
| | Apomorphine | 1 | 2001 | 5 | 0.010 |
Why?
| | Oxidopamine | 1 | 2001 | 12 | 0.010 |
Why?
| | Sympatholytics | 1 | 2001 | 14 | 0.010 |
Why?
| | Antiparkinson Agents | 1 | 2001 | 26 | 0.010 |
Why?
| | Parkinsonian Disorders | 1 | 2001 | 27 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 2001 | 245 | 0.010 |
Why?
| | Desipramine | 1 | 1999 | 9 | 0.010 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 1999 | 13 | 0.010 |
Why?
| | Locus Coeruleus | 1 | 1999 | 19 | 0.010 |
Why?
| | Naloxone | 1 | 1999 | 99 | 0.010 |
Why?
| | 14-3-3 Proteins | 1 | 1997 | 13 | 0.010 |
Why?
| | Phosphopeptides | 1 | 1997 | 15 | 0.010 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 1997 | 56 | 0.010 |
Why?
| | Narcotic Antagonists | 1 | 1999 | 139 | 0.010 |
Why?
| | Neurofilament Proteins | 1 | 1997 | 34 | 0.010 |
Why?
| | Recovery of Function | 1 | 2001 | 577 | 0.010 |
Why?
| | Receptor, Insulin | 1 | 1997 | 93 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1997 | 176 | 0.010 |
Why?
| | Cell Count | 1 | 1997 | 305 | 0.010 |
Why?
| | Substance Withdrawal Syndrome | 1 | 1999 | 160 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 1997 | 304 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1994 | 92 | 0.010 |
Why?
| | Binding Sites | 1 | 1997 | 1177 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 1994 | 214 | 0.010 |
Why?
| | Fibroblasts | 1 | 1997 | 839 | 0.010 |
Why?
| | Depression | 1 | 1999 | 1145 | 0.010 |
Why?
| | 3-Mercaptopropionic Acid | 1 | 1988 | 8 | 0.010 |
Why?
| | Biomarkers | 1 | 1997 | 3466 | 0.000 |
Why?
| | Pregnancy | 1 | 1997 | 5548 | 0.000 |
Why?
| | Chemistry | 1 | 1983 | 39 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1983 | 81 | 0.000 |
Why?
| | Homocysteine | 1 | 1983 | 135 | 0.000 |
Why?
| | Humans | 1 | 2011 | 115587 | 0.000 |
Why?
|
|
Freund's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|